U.S. Markets open in 34 hrs, 47 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,496.57 | 49.91 | 0.44% |
| NASDAQ | 2,282.78 | -29.52 | -1.28% |
| S&P 500 | 1,260.68 | 0.36 | 0.03% |
| Day Low 12:33 PM EDT | 25.47 | |
|---|---|---|
| Day High 09:31 AM EDT | 26.80 |
|
| Range | 1.33 | |
| Volume | 2.14 M | |
| 30-Day Avg. Vol. | 3.11 M |
|
| Difference | -31.22% | |
| Market Cap. | 3.52 B | |
| Change | -78.13 M | |
| Shares Out. | 137.07 M | |
| Percent Traded | 1.56% | |
| Revenue | 780.99 M | |
| Earnings | -211.13 M | |
| EPS (TTM) | -1.72 |
| 52-Wk Low 3/7/08 | 23.75 | |
|---|---|---|
| 52-Wk High 8/8/07 | 53.25 |
|
| Range | 29.50 | |
| Prev. Close 7/17/08 | 26.32 | |
| Today's Open | 26.36 | |
| Change | 0.15% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.8098 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Amylin Pharmaceuticals helps diabetics gain the upper hand in their battle with the disease. The company makes and markets two injectable diabetes drugs, Byetta and Symlin, that are approved as adjunct ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.44 12/31/07 | -0.57 12/31/07 |
-0.13
Missed
|
| Last Quarter | -0.477 3/31/08 | -0.51 3/31/08 |
-0.033
Missed
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 197.24 M | 781.00 M |
| Gross Profit | 175.21 M | 715.54 M |
| Operating Income | -70.14 M | -242.98 M |
| Net Income | -68.80 M | -211.14 M |
Real-Time Quote
